ロード中...
CD1d-antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses
Despite the well-established antitumor activity of CD1d-restricted invariant natural killer T lymphocytes (iNKT), their use for cancer therapy has remained challenging. This appears to be due to their strong but short-lived activation followed by long-term anergy after a single administration of the...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer-Verlag
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3624007/ https://ncbi.nlm.nih.gov/pubmed/23242316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-012-1381-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|